November 23, 2009 (FinancialWire) — Medidata Solutions, Inc. (NASDAQ: MDSO), a provider of hosted clinical development solutions, said it filed a registration statement with the Securities and Exchange Commission for a proposed public offering of 4.5 million shares of common stock of the company. Citigroup Global Markets (NYSE: C) and Credit Suisse Securities (NYSE: CS) are acting as joint bookrunning managers.

The shares are being offered by certain stockholders of the company, including funds affiliated with Insight Venture Partners. Medidata Solutions will not receive any of the proceeds from the intended offering. To the extent that the underwriters sell more than 4.5 million shares of common stock, the selling stockholders intend to grant the underwriters an option for a period of 30 days to purchase up to 675,000 additional shares of common stock.

Medidata Solutions products and services are meant to streamlin the design, planning and management of various aspects of the clinical development process, including protocol development, investigator benchmarking and budgeting, contract research organization benchmarking and budgeting, and the capture, management, analysis and reporting of clinical trial data.

Medidata’s customer base includes pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.